Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Franco Scaldaferri
Observed names:
F Scaldaferri,
Franco SCALDAFERRI
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0000-0001-8334-7541
Observed ORCID:
0000-0001-8334-7541
OpenAlex ID:
A5123472122
Inflammatory bowel disease (IBD) is associated with increased intestinal extrachromosomal circular DNA: an emerging biomarker for IBD type and activity
2025
·
Valentina Petito
, Daniela Gerovska
, et al.
·
Journal of Crohn s and Colitis
·
3
Implementing a hospital at home televisitation program run by a tertiary university hospital: Applying failure modes and effect analysis (FMEA) for improving patient safety and sustainable care
2025
·
Riccardo Tartaglia
, Chiara Parretti
, et al.
·
Safety Science
·
3
Validation of the Ontario Protocol Assessment Level (OPAL) Tool for Assessing Clinical Trial Complexity and Supporting Workforce Planning in the Italian Clinical Research Context
2026
·
Daniele Napolitano
, Mattia Bozzetti
, et al.
·
Therapeutic Innovation & Regulatory Science
·
2
PDF
Nursing‐Led Support Across the Standard Care–Clinical Trial–Standard Care Pathway in Inflammatory Bowel Disease: A Review With Realist‐Informed Interpretation
2026
·
Daniele Napolitano
, Mattia Bozzetti
, et al.
·
JGH Open
·
1
PDF
Analysis of possible baseline and treatment-course factors associated with non-remission in patients with Crohn’s disease treated with ustekinumab: a retrospective real-life analysis
2026
·
Antonio Tursi
, Raffaele Pellegrino
, et al.
·
Pharmacological Reports
·
1
PDF
The Heart–Gut Axis in Heart Failure: The Role of Next-Generation Pharmacological Therapies
2026
·
Elia Nunzio Maria Salerno
, Isabella Fumarulo
, et al.
·
International Journal of Molecular Sciences
·
1
PDF
Five-Year Real-World Hard Outcomes of Vedolizumab in Inflammatory Bowel Disease: The IG-IBD LONG-LIVE Study
2026
·
Giuseppe Privitera
, Flavia Palumbo
, et al.
·
Advances in Therapy
PDF
Neurofeedback as a non-pharmacological strategy for pain and gut-brain axis disorders: clinical relevance in inflammatory bowel disease
2026
·
Giorgia SPAGNOLO
, Daniele FERRARESE
, et al.
·
Minerva Gastroenterology
Adverse Childhood Experiences and Disease Activity Are Associated with Post-Traumatic Stress Symptoms in Crohn’s Disease
2026
·
Giorgia Spagnolo
, Daniele Ferrarese
, et al.
·
Advances in Therapy
PDF
P0135 A Chronic Model of Experimental IBD Reveals Sarcopenia and Long-Term Motor Dysfunction
2026
·
S Troisi
, L Masi
, et al.
·
Journal of Crohn s and Colitis
PDF
Show more works
View as search
Works count:
10
Citation count:
11
H-index:
2
I10-index:
Year
Topic
Type